2003
DOI: 10.1523/jneurosci.23-17-06754.2003
|View full text |Cite
|
Sign up to set email alerts
|

Post-Training Intra-Basolateral Amygdala Infusions of Norepinephrine Enhance Consolidation of Memory for Contextual Fear Conditioning

Abstract: Post-training infusions of drugs, including noradrenergic agonists and antagonists, into the basolateral amygdala (BLA) influence the consolidation of memory for training in several tasks, including inhibitory avoidance. There is, however, conflicting evidence concerning whether post-training intra-BLA drug infusions modulate the consolidation of contextual fear conditioning (CFC). In the present study, norepinephrine (NE) was infused bilaterally into the BLA of male Sprague Dawley rats immediately after train… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

11
118
2
2

Year Published

2005
2005
2014
2014

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 181 publications
(133 citation statements)
references
References 33 publications
(37 reference statements)
11
118
2
2
Order By: Relevance
“…the concentrations used in this study, which correspond to sub-threshold levels for receptor activation via a mono-target mechanism, are only able to evoke physiological effects by synergistic activation of several neurotransmitter systems (Youdim and Buccafusco, 2005;Cavalli et al, 2008). The memory-enhancing effects of dimebon may indicate simultaneous activity toward AMPA, NMDA, dopamine and serotonin receptors, all of which have been involved in inhibitory and appetitive hippocampus-dependent learning (Ungerer et al, 1998;Orsetti et al, 2001;Rogawski and Wenk, 2003;LaLumiere et al, 2003;Lynch and Gall, 2006;Balschun et al, 2006;Da Silva Costa et al, 2009;Benchenane et al, 2010). In particular, it has been hypothesised that dimebon's activity as a positive modulator of AMPA receptors and low affinity non-competitive blocker of NMDA receptors via a multi-drug mechanism, can explain the pro-cognitive action of this compound (Grigorev et al, 2003;Grigoriev 2009).…”
Section: Discussionmentioning
confidence: 96%
“…the concentrations used in this study, which correspond to sub-threshold levels for receptor activation via a mono-target mechanism, are only able to evoke physiological effects by synergistic activation of several neurotransmitter systems (Youdim and Buccafusco, 2005;Cavalli et al, 2008). The memory-enhancing effects of dimebon may indicate simultaneous activity toward AMPA, NMDA, dopamine and serotonin receptors, all of which have been involved in inhibitory and appetitive hippocampus-dependent learning (Ungerer et al, 1998;Orsetti et al, 2001;Rogawski and Wenk, 2003;LaLumiere et al, 2003;Lynch and Gall, 2006;Balschun et al, 2006;Da Silva Costa et al, 2009;Benchenane et al, 2010). In particular, it has been hypothesised that dimebon's activity as a positive modulator of AMPA receptors and low affinity non-competitive blocker of NMDA receptors via a multi-drug mechanism, can explain the pro-cognitive action of this compound (Grigorev et al, 2003;Grigoriev 2009).…”
Section: Discussionmentioning
confidence: 96%
“…Norepinephrine has been implicated as well in fear memory consolidation in more traditional Pavlovian fear conditioning paradigms 265,266 although there is some dispute as to the precise nature of its role. 267 Adrenergic involvement in extinction has been the topic of two recent studies, both of which employed Pavlovian fear conditioning in mice with freezing as a measure of conditioned fear.…”
Section: Neurotransmitter Systemsmentioning
confidence: 99%
“…All drugs were freshly prepared before the experiments. The doses of the drugs (10 mg/ml propranolol, 100 mg/ml anisomycin, 25 mg/ml emetine, 1.0 mg/ml Rp-cAMPs, and 0.3 or 1.0 mg/ml NE) were based on previous studies (LaLumiere et al, 2003;Lima et al, 2009;Moncada et al, 2011). The infusion volume of NE was 1.0 ml, and the infusion volume of the other drugs was 0.5 ml to minimize the total infusion volume (Katche et al, 2010).…”
Section: Intracranial Injectionsmentioning
confidence: 99%